PsyAccess
Am I eligible?
Am I eligible?
Spravato®Registry-verifiedDesignated-centers model

Zentrum für Angst und Depression Zürich (ZADZ)

Zürich, Switzerland

Treatment & access

  • Treatments offeredEsketamine nasal spray (Spravato®)
  • Access routeCovered by a national programme
  • Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 44 386 66 00
  • Websitehttps://zadz.ch/

About this provider

The Zentrum für Angst- und Depressionsbehandlung Zürich (ZADZ), located at Riesbachstrasse 61 in Zurich's Seefeld district, is a psychiatric-psychotherapeutic outpatient clinic specialising in anxiety and depression treatment for patients of all ages. A team of around 40, including specialists in psychiatry and psychotherapy and psychological psychotherapists, provides assessment and integrative treatment, complemented by certified respiratory and physiotherapists, career coaching, social work, nutritional counselling and psychiatric nursing. ZADZ is part of the Clienia Group and participates in clinical research, primarily with the Psychiatric University Hospital Zurich.

Services & programs

  • Outpatient psychiatric and psychotherapeutic treatment of anxiety disorders and depression
  • Psychiatric assessment and integrative treatment planning
  • Psychological psychotherapy
  • Complementary therapies (respiratory therapy, physiotherapy, nutritional counselling)
  • Career coaching, social work and psychiatric nursing
  • Participation in clinical research projects with the Psychiatric University Hospital Zurich

Common questions

How do I become a patient at ZADZ?

ZADZ is an outpatient clinic reachable on 044 386 66 00 or info@zadz.ch. For Spravato treatment under Swiss basic insurance, a psychiatrist must confirm the Limitatio criteria and obtain the insurer's cost approval (Kostengutsprache) before the first dose.

What does Swiss reimbursement of Spravato require?

Adults 18-74 whose current episode has not responded to at least two antidepressants plus one augmentation attempt, CGI-S severity of 5 or more, insurer pre-approval before the first administration, and a maximum reimbursed duration of 10 months.

Looking at alternatives? One of the BAG-designated Spravato centers; see the country guide and the limited-medical-use PAT program.

33 more verified providers within 50 km

See them on the provider map →

Practical details

As stated on the provider's own website (checked 2026-09-09); details can change — confirm when you book.

  • BookingDirect booking possible — the provider states no referral is required. Source →

Verification

At least one source for this record is a public state registry or an official public-law register. The registry entry is linked below and re-checked at least every 90 days.

Spotted an error? See our methodology for how records are checked and how to report a correction.

Check your fit & enquire

Spravato® access in Switzerland follows published criteria. A short pre-screening comes first, then your compiled summary goes to Zentrum für Angst und Depression Zürich (ZADZ) only with your explicit consent, and you can download it for yourself either way.

Why enquire via PsyAccess

  • Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
  • A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
  • Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.
Check my fit & enquire

About two minutes. The check itself runs in your browser: your answers are never sent anywhere unless you choose to send them. We count only anonymous usage events.

Check my fit & enquire